Integrated Programs enabled by Translational Pharmaceutics at Quotient Sciences

CPHI Milan 2026

Milan, Italy | 6 October 2026 - 8 October 2026
Overview

Connect with Quotient Sciences’ experts who will be attending the CPHI Milan 2026 event taking place in Milan on October 6-8, 2026. 

Meet our Business Development team to learn more about our expanded capabilities and how we can help you with your next project.  

You can schedule a partnering meeting with our experts by using the button below.  

Request a meeting with us:
Location
Fiera Milano
Strada Statale Sempione 28, 20017
Milan, Italy

Meet our experts:

We look forward to meeting you at the CPHI Milan 2026 this October.

Charlotte Hannigan

Director, Business Development

Charlotte Hannigan is a Director of Business Development at Quotient Sciences. She plays a key role in supporting the company’s mi...

About Charlotte
Christian Hoenig

Director, Business Development

Christian Hoenig is a Business Development Director at Quotient Sciences specialising in new business within the Nordic and BeNeLu...

About Christian
David Ross

Senior Director, Business Development

David Ross has around 20 years of career experience within the pharmaceutical industry across various disciplines, sectors, and th...

About David
Adam Ball

Associate Director, Business Development

Adam Ball has worked at Quotient Sciences for over 7 years, starting in manufacturing in 2018 before moving into the commercial te...

About Adam
Emily Dodds

Research Fellow, Scientific Consulting

Emily Dodds has worked at Quotient Sciences for over five years, specialising in the design, execution, and review of Phase 1 clin...

About Emily
Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Dr. Andrew Parker

Executive Drug Development Consultant

Dr. Andrew Parker has over two decades of experience in the pharmaceutical industry, spanning from preclinical development, throug...

About Andrew
John McDermott

VP, Scientific Consulting

John McDermott leads Quotient Sciences' global drug development consulting, research fellows, modeling & simulation, and clien...

About John
Dr. Asma Patel

VP, Global Commercial and Scientific Consulting - Drug Product

Dr. Asma Patel is responsible for providing scientific and technical support to Quotient Sciences' business development group and ...

About Asma

More insight from our experts:

Read More
Drug Product, Pediatrics, Nazim Kanji A Comparison of FDA and EMA Expectations for Oral Drug Administration Through Enteral Feeding Tubes
Read More
Drug Product, Commercial Manufacturing, Clinical Trial Manufacturing, Translational Pharmaceutics, Regulatory, Orphan Rare, FDA Navigating Expedited Drug Development Pathways Globally: Q&A with Quotient Sciences Experts
Read More
Pediatrics, Formulation Development, Drug Product A Comprehensive Approach to Pediatric Drug Products: Q&A with Nazim Kanji
Read More
Read More